4-Iodopyrimidine Labeling Reveals Nuclear Translocation and Nuclease Activity for Both MIF and MIF2

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Macrophage migration inhibitory factor (MIF) and its homolog MIF2 (D-dopachrome tautomerase/DDT) are implicated in critical cellular processes, including cell growth and immune responses.
• Dysregulated expression of MIF and MIF2 is observed in various cancers and neurodegenerative diseases, highlighting their pathological significance.
• Efficient detection methods for MIF and MIF2 are essential for advancing research into their roles in disease pathogenesis.

Purpose of the Study:

• To develop a selective and convenient chemical probe for the detection and imaging of MIF and MIF2.
• To utilize the developed probe for in situ visualization of MIF2 dynamics within cells.
• To investigate the enzymatic activity of MIF2, particularly its interaction with human genomic DNA.

Main Methods:

• Synthesis and application of a novel 4-iodopyrimidine-based probe (Probe 8) designed for selective labeling of MIF and MIF2.
• In situ imaging of MIF and MIF2 using the fluorophore-conjugated probe.
• Stimulation of HeLa cells with methylnitronitrosoguanidine to induce cellular responses and observe protein translocation.
• Biochemical assays to identify the nuclease activity of MIF2 on human genomic DNA.

Main Results:

• Successful development of Probe 8, enabling selective labeling and in situ imaging of both MIF and MIF2.
• Visualization of MIF2 translocation from the cytoplasm to the nucleus in response to methylnitronitrosoguanidine stimulation.
• Identification of nuclease activity for MIF2 against human genomic DNA, a novel finding supported by prior literature on MIF.

Conclusions:

• Probe 8 represents a valuable tool for the selective detection and imaging of MIF and MIF2, facilitating research in cancer and neurodegenerative diseases.
• The study provides the first evidence of MIF2 exhibiting nuclease activity on human genomic DNA.
• This discovery opens new avenues for understanding the molecular mechanisms of MIF2 in cellular functions and disease states.